Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
収録刊行物
-
- EBioMedicine
-
EBioMedicine 47 446-456, 2019-09
Elsevier BV